HidehoOkadaMD
Neurosurgery • San Francisco, CAAssociate Professor, Neurological Surgery, University of Pittsburgh School of Medicine
Dr. Okada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1450 3rd Street
San Francisco, CA 94158Phone+1 415-476-1637- Is this information wrong?
Education & Training
Nagoya University - School of MedicineClass of 1991
Certifications & Licensure
PA State Medical License 2004 - 2014
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Clinical Trials
- H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas Start of enrollment: 2016 Nov 18
Publications & Presentations
PubMed
- IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma.Megan Montoya, Sara A Collins, Pavlina Chuntova, Trishna S Patel, Takahide Nejo, Akane Yamamichi, Noriyuki Kasahara, Hideho Okada> ;Biorxiv. 2024 Apr 3
- Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.Takahide Nejo, Lin Wang, Kevin K Leung, Albert Wang, Senthilnath Lakshmanachetty, Marco Gallus, Darwin W Kwok, Chibo Hong, Lee H Chen, Diego A Carrera, Michael Y Zhang...> ;Scientific Reports. 2024 Mar 16
- Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment.Ryusuke Hatae, Keith Kyewalabye, Akane Yamamichi, Tiffany Chen, Su Phyu, Pavlina Chuntova, Takahide Nejo, Lauren S Levine, Matthew H Spitzer, Hideho Okada> ;JCI Insight. 2024 Apr 8
- Join now to see all
Journal Articles
- Immunotherapy of Primary Brain Tumors: Facts and HopesHideho Okada, MD, Clinical Cancer Research
- Single-Cell Profiling of Human Gliomas Reveals Macrophage Ontogeny as a Basis for Regional Differences in Macrophage Activation in the Tumor MicroenvironmentDaniel A Lim, S John Liu, Manish Aghi, Hideho Okada, Nduka M Amankulor, Arnold R Kriegstein, BioMed Central
Press Mentions
Next-Generation T-cell Therapeutics Set Sights on Cancers, Autoimmune Disorders and MoreJune 17th, 2021- Engineered Immune Cells Eliminate Brain Cancer in MiceMay 25th, 2021
- Smart Cell Therapies for Solid Cancers Ready to Move Toward Clinical TrialsApril 28th, 2021
- Join now to see all
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
